Theratechnologies Inc T.TH

Exercise of Options

[archeo753]

Filed 2022-07-24 20:03   Tx date 2022-07-21	$TH Theratechnologies Inc.	Lafond, Jocelyn 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-8,550 -3,000 vol $2.85 each	18,000
Filed 2022-07-24 20:02   Tx date 2022-07-21	$TH Theratechnologies Inc.	Lafond, Jocelyn 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,272 -800 vol $2.84 each	21,000
Filed 2022-07-24 20:01   Tx date 2022-07-21	$TH Theratechnologies Inc.	Lafond, Jocelyn 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-17,546 -6,200 vol $2.83 each	21,800
Filed 2022-07-24 20:01   Tx date 2022-07-19	$TH Theratechnologies Inc.	Lafond, Jocelyn 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-8,250 -3,000 vol $2.75 each	28,000
Filed 2022-07-24 20:00   Tx date 2022-07-19	$TH Theratechnologies Inc.	Lafond, Jocelyn 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-7,000 vol	31,000
Filed 2022-07-24 19:57   Tx date 2022-07-19	$TH Theratechnologies Inc.	Lafond, Jocelyn 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,600 +20,000 vol $0.38 each	38,000
Filed 2022-07-24 19:56   Tx date 2022-07-19	$TH Theratechnologies Inc.	Lafond, Jocelyn 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,600 -20,000 vol $0.38 each	414,857

[Wino115]

Looks like he exercised and then sold 20,000 shares. There may be personal circumstances around it and I'm sure he ran it by CEO (who must have agreed), but not a great sign if there were no personal reasons.   If you believed there would soon be news of efficacy after 2 years of waiting, you wouldn't sell. You would buy.  Disappointing in general, but willing to see if there

[Trogarzon]

Listen he just told you and us there is no short term upside in the stock and that he does,not believe in   Oncology.... as simple as that ... otherwise the borrowing cost wold be redicoulus and he’s to broke to be a shareholder.

[palinc2000]

This is really crappy at least optically I dont want to spend the time to search what was the expiration date of the options but even if the expiry date was close he could have exercised now and not sell That would have been an out of pocket cost of 7600 $ now plus additional income taxes in April 2022 of less than 10000$ I hope this is not another Lyne moment!!!

[PWIB123]

Why aren't those filings showing on Sedar or Edgar?  Sometimes companies will put an explanation in the description of an insider trade, such as donated to charity or forfeiture of shares to pay taxes from shareholder compensation plan. The timing of this insider sell couldn't be any worse.  I have been so excited about the near-term prospects, but this definitely tempers my

[PWIB123]

Remember this article from last year?  I'd say he has a deep understanding of what's happening inside the company.  https://www.vanguardlawmag.com/case-studies/jocelyn-lafond-theratechnologies/

[Wino115]

Yes!  He "appreciates the company's willingness to take risks", but he appears unwilling to do this himself!  His actions don't sit well with that article.  

[jfm1330]

Lafond did the same a few years ago and there was the same resentment towards him here at the time. They are not in blackout period, it means that V-P unrelated to science and clinical trials like him don't have much more infos on the trial than what we have. This is also one of the downside of granting stock options.

[jfm1330]

The other thing, at an exercise price of 0.38$, these were probably options about to expire. 

[Biobob]

considering the ACB and the SUPPOSED potential.. you keep them... your risk is pretty low.....

[Wino115]

Point being, Paul should have said "absolutely no" given where we are in the trial, what you are responsible for, and for the horrible optics. Exercise and keep like any other manager for a small biotech selling near a 52 week low would sensibly do.  We can only hope he's wrong and it's $10 in a few months and he's reminded on the next call!

[Trogarzon]

Tanguey used to having the same kind of issues with Pierre Parazelli, Marie-Noel Collusi, Lybe Fortin among others... he can't do anything about it apart from being verbal about it... it's lack of judgemnent from this guy and it's bringing hard work from IR to a stall... the only way to fic this is for others to BUY more than 5 shares... like 50 000 shares ..

[palinc2000]

Those filings  appear on Sedi.ca...The reason I think is quite simple ,,,the options were about to expire and he exercised and sold the same day so not to risk any cash outlays,,,,

[palinc2000]

Lafond still has 386000 options ! He has been an insider since 2007  

[Biobob]

Conter intuitive, counter productive..... bad timing... the partnerships, deals, patents... commercial liabilities... it all go trough his hands... look like sh..t to me... 

[palinc2000]

I have looked at all his transactions on Sedi Sickening He exercised 35000 options in in April 2018 and sold at 9.40 esch and he exercised again un April 2019 30000 options at 1.80 and sold at 7.12$   His total stock holdings at this moment is 18000 shares !!!!   

[Wino115]

I have heard many cases where unless there's some extenuating circumstances (which can still be the case here) a CEO will "strongly urge" his management team not to sell until a particular strategic objective has been attained...say, a milestone like commencing Phase 2, or even  further out like FDA approval. He can't hold anyone to it legally, but he can make it known he